CHOLECYSTITIS CHRONIC

This adverse event was reported 6701 times

CHOLECYSTITIS CHRONIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholecystokinin Analog [EPC] 3 0.0196
1 Bismuth [EPC] 39 0.0070
2 beta Lactamase Inhibitor [EPC] 30 0.0067
3 Pyrethroid [EPC] 10 0.0057
4 Nitrofuran Antibacterial [EPC] 82 0.0047
5 Aluminum Complex [EPC] 106 0.0044
6 Barbiturate [EPC] 46 0.0040
7 Melanin Synthesis Inhibitor [EPC] 4 0.0035
8 Provitamin D2 Compound [EPC] 99 0.0033
9 Classical Complement Pathway Inhibitor [EPC] 1 0.0031
See all drug classes enriched for association with CHOLECYSTITIS CHRONIC